Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors
Xencor, Inc.
Xencor, Inc.
Context Therapeutics Inc.
BioNTech SE
Jonsson Comprehensive Cancer Center
City of Hope Medical Center
West China Hospital
Jonsson Comprehensive Cancer Center
Columbia University
City of Hope Medical Center
Seagen Inc.
Astellas Pharma Inc
Second Affiliated Hospital of Guangzhou Medical University
National Cancer Institute (NCI)
Indiana University
Abramson Cancer Center at Penn Medicine
Celgene
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Wake Forest University Health Sciences
Masonic Cancer Center, University of Minnesota
University of Louisville
Alliance for Clinical Trials in Oncology
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals
Northwestern University
National Cancer Institute (NCI)
Indiana University
Duke University
Children's Oncology Group
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Duke University
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Alaunos Therapeutics
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Case Comprehensive Cancer Center
National Institutes of Health Clinical Center (CC)